LCO 4882 \\PRDFS1\SCOUSERS\FORZANOF\WS\2019SB-00004-R04-
SB.docx
1 of 2
General Assembly Committee Bill No. 4
January Session, 2019
LCO No. 4882
Referred to Committee on PUBLIC HEALTH
Introduced by:
(PH)
AN ACT CONCERNING THE A CCESSIBILITY OF PRESCRIPTION
DRUGS.
Be it enacted by the Senate and House of Representatives in General
Assembly convened:
Section 1. (Effective July 1, 2019) The Department of Public Health, in 1
collaboration with the Department of Consumer Protection, shall study 2
the public health impact of a person not taking medication prescribed 3
to such person by his or her health care provider, or not taking such 4
medication as directed, because he or she cannot afford to pay for such 5
medication. Such study shall include, but not be limited to, strategies 6
to improve patient access to medication prescribed by the patient's 7
health care provider. On or before January 1, 2020, the Commissioners 8
of Public Health and Consumer Protection shall report, in accordance 9
with the provisions of section 11-4a of the general statutes, to the joint 10
standing committees of the General Assembly having cognizance of 11
matters relating to public health and consumer protection regarding 12
the findings of such study. 13
This act shall take effect as follows and shall amend the following
sections:
Committee Bill No. 4
LCO 4882 {\\PRDFS1\SCOUSERS\FORZANOF\WS\2019SB-00004-
R04-SB.docx }
2 of 2
Section 1 July 1, 2019 New section
PH Joint Favorable
INS Joint Favorable
APP Joint Favorable